Brief: GT Biopharma Reports Fourth Quarter Net Loss Of $18.0 Mln

GT Biopharma

28/03/2022 21:46

March 28 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA REPORTS FOURTH QUARTER AND FULL-YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * GT BIOPHARMA INC - CASH AND CASH EQUIVALENTS EXPECTED TO
PROVIDE
AMPLE RUNWAY TO FUND OPERATIONS INTO 2023
    * GT BIOPHARMA INC - FOR Q4 OF 2021, COMPANY REPORTED A NET
LOSS
OF $18.0 MILLION

Source text for Eikon:  ID:nPn56K3n7a 
Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;))